Inventor · disambiguated record
Eduardo A. Padlan
Also filed as: PADLAN EDUARDO · PADLAN EDUARDO A · PADLAN EDUARDO AGUSTIN
30 granted patents·8 pending applications·945 citations·filing 1992–2018
97Inventor score
Top patents by PatentIndex Score
38 records- 0197US6797492B2Method for reducing the immunogenicity of antibody variable domainsMERCK & CO INC·Filed 2001·Granted Sep 28, 2004·261 cites·3 claims
- 0296US6818749B1Variants of humanized anti carcinoma monoclonal antibody cc49US HEALTH·Filed 1999·Granted Nov 16, 2004·133 cites·47 claims
- 0396US6001358AHumanized antibodies to human gp39, compositions containing thereofIDEC PHARMA CORP·Filed 1995·Granted Dec 14, 1999·125 cites·12 claims
- 0490US7256004B2Variants of humanized anti-carcinoma monoclonal antibody CC49US HEALTH·Filed 2004·Granted Aug 14, 2007·21 cites·19 claims
- 0589US6005091ANucleic acids encoding immunoglobulin domainsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Dec 21, 1999·57 cites·7 claims
- 0689US5889157AHumanized B3 antibody fragments, fusion proteins, and uses thereofUS HEALTH·Filed 1994·Granted Mar 30, 1999·64 cites·21 claims
- 0788US8101179B2Anti-CD20 monoclonal antibodyNUMAZAKI MASANORI·Filed 2006·Granted Jan 24, 2012·52 cites·10 claims
- 0888US7919607B2Nucleic acids encoding humanized anti-tag 72 CC49 antbodiesUS HEALTH·Filed 2009·Granted Apr 5, 2011·3 cites·17 claims
- 0987US9512204B2Humanized pertussis antibodies and uses thereofUNIV TEXAS·Filed 2015·Granted Dec 6, 2016·7 cites·5 claims
- 1085US7074406B2Treating allergic diseases with humanized anti-CD40L antibodyBIOGEN IDEC INC·Filed 2002·Granted Jul 11, 2006·14 cites·9 claims
- 1184US6495137B1Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chainsDOW CHEMICAL CO·Filed 1997·Granted Dec 17, 2002·45 cites·20 claims
- 1283US6391299B1Anti-factor IX/IXa antibodiesSMITHKLINE BEECHAM CORP·Filed 1999·Granted May 21, 2002·33 cites·13 claims
- 1382US7915396B2Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49US HEALTH·Filed 2009·Granted Mar 29, 2011·3 cites·14 claims
- 1482US7589181B2Minimally immunogenic variants of SDR-grafted humanized antibody CC49 and their useUS HEALTH·Filed 2004·Granted Sep 15, 2009·6 cites·36 claims
- 1581US8835167B2Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumorsUS HEALTH·Filed 2013·Granted Sep 16, 2014·2 cites·7 claims
- 1680US7179899B2Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72US HEALTH·Filed 2002·Granted Feb 20, 2007·5 cites·6 claims
- 1780US6440418B1Methods of treating autoimmune diseases with gp39-specific antibodiesIDEC PHARMA CORP·Filed 1997·Granted Aug 27, 2002·36 cites·16 claims
- 1878US10035846B2Humanized pertussis antibodies and uses thereofUNIV TEXAS·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 1977US8535890B2Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodiesKASHMIRI SYED V S·Filed 2011·Granted Sep 17, 2013·4 cites·19 claims
- 2076US8029788B2Variants of humanized anti-carcinoma MAb CC49US HEALTH·Filed 2010·Granted Oct 4, 2011·2 cites·15 claims
- 2172US7569673B2Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumorsUS HEALTH·Filed 2003·Granted Aug 4, 2009·3 cites·49 claims
- 2267US6315997B1Use of modified antibodies with human milk fat globule specificityCANCER RES FUND·Filed 1997·Granted Nov 13, 2001·28 cites·65 claims
- 2366US7763719B2Variants of humanized anti-carcinoma MAb CC49US HEALTH·Filed 2007·Granted Jul 27, 2010·0 cites·23 claims
- 2464US6936706B2Modified antibodies with human milk fat globule specificity and usesFiled 2001·Granted Aug 30, 2005·4 cites·73 claims
- 2561US10526400B2Humanized pertussis antibodies and used thereofUNIV TEXAS·Filed 2018·Granted Jan 7, 2020·0 cites·4 claims
- 2659US2004253645A1Method for reducing the immunogenicity of antibody variable domainsFiled 2004·Application pending·0 cites
- 2759US2006147446A1Humanized antibodies to human GP39, compositions, and therapeutic uses thereofBLACK AMELIA·Filed 2006·Application pending·0 cites
- 2858US6506383B1Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodiesIDEC PHARMA CORP·Filed 1999·Granted Jan 14, 2003·9 cites·27 claims
- 2958US6287562B1Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugatesUS HEALTH·Filed 1999·Granted Sep 11, 2001·9 cites·16 claims
- 3058US5792852APolynucleotides encoding modified antibodies with human milk fat globule specificityCANCER RES FUND OF CONTRACOSTA·Filed 1992·Granted Aug 11, 1998·17 cites·63 claims
- 3158US2002146411A1Anticoagulant agents useful in treatment of thrombosisSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 3258US2009004208A1Method for designing hypoallergenic molecules for use in allergy desensitization with lessened chance of anaphylaxis, or as vaccines against allergic reactionsPADLAN EDUARDO A·Filed 2007·Application pending·0 cites
- 3357US2007003553A1Anticoagulant agents useful in treatment of thrombosisSMITHKLINE BEECHAM CORP AND TH·Filed 2005·Application pending·0 cites
- 3456US2006153837A1Treating autoimmune diseases with humanized anti-CD401 antibodiesBLACK AMELIA·Filed 2006·Application pending·0 cites
- 3555US2009162383A1Method for designing vaccines against constantly mutating pathogensPADLAN EDUARDO A·Filed 2006·Application pending·0 cites
- 3653US2006216303A1Processes and products with modified antibodies of human milk fat globule specificityDO COUTO FERNANDO J·Filed 2004·Application pending·0 cites
- 3751US7855276B2Framework residue substituted humanized COL-1 antibodies and their useUS HEALTH·Filed 2005·Granted Dec 21, 2010·0 cites·47 claims
- 3850US8828717B2Framework residue substituted humanized COL-1 antibodies and their useSCHLOM JEFFREY·Filed 2010·Granted Sep 9, 2014·0 cites·30 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →